{"id":371763,"title":"Qualifying notice amendment for Folotyn (278618) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-04-11","captureTimestamp":"2026-04-11T15:17:32.251000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions/qualifying-notice-amendment-folotyn-278618.html","snippet":"Qualifying notice amendment for Folotyn (278618) Pharmaceutical Drugs Directorate Holland Cross, Tower \"B\" 6th Floor, 1600 Scott Street Address Locator #3106B Ottawa ON K1A 0K9 Dossier identifier: HC6-024-e196129 Control number: 278618 Servier Canada Inc. [name of employee…","rawSnapshotUrl":"/api/snapshots/raw/371763","browseUrl":"https://replay.healtharchive.ca/job-6/20260411151732/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions/qualifying-notice-amendment-folotyn-278618.html#ha_snapshot=371763","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}